Dynamk Capital is a venture capital firm dedicated to funding the future of life sciences. Based in New York City, the firm focuses on investing in innovative companies that are advancing the fields of biotechnology, pharmaceuticals, and medical devices. Their portfolio includes companies such as Alpenglow Biosciences, Virica Biotech, Vectron Biosolutions, Curibio, Lucid Scientific, Envisagenics, CellFE Biotech, and RoosterBio.

Dynamk Capital is committed to supporting entrepreneurs and investors in the life sciences sector, providing them with the resources and expertise needed to bring groundbreaking solutions to market.